Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
Major depressive disorder (MDD) is a common disorder involving depressive mood and decreased motivation. Due to its high heterogeneity, novel biomarkers are required to diagnose MDD. In this study, a proteomic method was used to identify a new MDD biomarker. Using sequential window acquisition of al...
Main Authors: | Hyebin Choi, Sora Mun, Eun-Jeong Joo, Kyu Young Lee, Hee-Gyoo Kang, Jiyeong Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/3/539 |
Similar Items
-
Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
by: Seungyeon Lee, et al.
Published: (2022-11-01) -
Fungal Secretome for Biorefinery: Recent Advances in Proteomic Technology
by: Adav, Sunil S., et al.
Published: (2016) -
Network-Based Protein Biomarker Discovery Platforms
by: Minhyung Kim, et al.
Published: (2016-03-01) -
Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
by: Becky C. Carlyle, et al.
Published: (2018-08-01) -
Proteomic dataset of Candida albicans (ATCC 10231) Biofilm
by: Gajanan Zore, et al.
Published: (2023-07-01)